Dudley ME - Search Results

1

Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.

Hughes MS, Yu YY, Dudley ME, Zheng Z, Robbins PF, Li Y, Wunderlich J, Hawley RG, Moayeri M, Rosenberg SA, Morgan RA. Hughes MS, et al. Among authors: dudley me. Hum Gene Ther. 2005 Apr;16(4):457-72. doi: 10.1089/hum.2005.16.457. Hum Gene Ther. 2005. PMID: 15871677 Free PMC article.

2

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.

Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE. Rosenberg SA, et al. Among authors: dudley me. Nat Med. 1998 Mar;4(3):321-7. doi: 10.1038/nm0398-321. Nat Med. 1998. PMID: 9500606 Free PMC article. Clinical Trial.

3

High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy.

Zeh HJ 3rd, Perry-Lalley D, Dudley ME, Rosenberg SA, Yang JC. Zeh HJ 3rd, et al. Among authors: dudley me. J Immunol. 1999 Jan 15;162(2):989-94. J Immunol. 1999. PMID: 9916724

4

Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads to a functionally heterogeneous CTL response.

Dudley ME, Nishimura MI, Holt AK, Rosenberg SA. Dudley ME, et al. J Immunother. 1999 Jul;22(4):288-98. doi: 10.1097/00002371-199907000-00002. J Immunother. 1999. PMID: 10404430

5

T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes.

Dudley ME, Ngo LT, Westwood J, Wunderlich JR, Rosenberg SA. Dudley ME, et al. Cancer J. 2000 Mar-Apr;6(2):69-77. Cancer J. 2000. PMID: 11069222

6

Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer.

Parker LL, Do MT, Westwood JA, Wunderlich JR, Dudley ME, Rosenberg SA, Hwu P. Parker LL, et al. Among authors: dudley me. Hum Gene Ther. 2000 Nov 20;11(17):2377-87. doi: 10.1089/104303400750038480. Hum Gene Ther. 2000. PMID: 11096442

7

TCR stimulation protects CD8+ T cells from CD95 mediated apoptosis.

Karas M, Zaks TZ, Yakar S, Dudley ME, LeRoith D. Karas M, et al. Among authors: dudley me. Hum Immunol. 2001 Jan;62(1):32-8. doi: 10.1016/s0198-8859(00)00223-8. Hum Immunol. 2001. PMID: 11165713

8

Kinetics of TCR use in response to repeated epitope-specific immunization.

Monsurrò V, Nielsen MB, Perez-Diez A, Dudley ME, Wang E, Rosenberg SA, Marincola FM. Monsurrò V, et al. Among authors: dudley me. J Immunol. 2001 May 1;166(9):5817-25. doi: 10.4049/jimmunol.166.9.5817. J Immunol. 2001. PMID: 11313426

9

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.

Dudley ME, Wunderlich J, Nishimura MI, Yu D, Yang JC, Topalian SL, Schwartzentruber DJ, Hwu P, Marincola FM, Sherry R, Leitman SF, Rosenberg SA. Dudley ME, et al. J Immunother. 2001 Jul-Aug;24(4):363-73. doi: 10.1097/00002371-200107000-00012. J Immunother. 2001. PMID: 11565838 Clinical Trial.

10

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.

Dudley ME, Wunderlich JR, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry RM, Marincola FM, Leitman SF, Seipp CA, Rogers-Freezer L, Morton KE, Nahvi A, Mavroukakis SA, White DE, Rosenberg SA. Dudley ME, et al. J Immunother. 2002 May-Jun;25(3):243-51. doi: 10.1097/01.CJI.0000016820.36510.89. J Immunother. 2002. PMID: 12000866 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page